UK markets closed
NIKKEI 225
38,236.07 -38.03 (-0.10%) HANG SENG
18,475.92 +268.82 (+1.48%) CRUDE OIL
78.44 +0.33 (+0.42%) GOLD FUTURES
2,311.00 +2.40 (+0.10%) DOW
38,675.68 +449.98 (+1.18%) Bitcoin GBP
50,951.90 +126.59 (+0.25%)
Divi's Laboratories Limited (DIVISLAB.BO)
BSE - BSE Real-time price. Currency in INR
Add to watchlist
At close: 03:29PM IST
| Previous close | 3,964.05 |
| Open | 3,974.60 |
| Bid | 3,953.45 x 0 |
| Ask | 3,954.00 x 0 |
| Day's range | 3,900.00 - 3,982.00 |
| 52-week range | 3,050.15 - 4,104.00 |
| Volume | |
| Avg. volume | 12,939 |
| Market cap | 1.045T |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | 75.49 |
| EPS (TTM) | 52.15 |
| Earnings date | 18 May 2024 - 22 May 2024 |
| Forward dividend & yield | 30.00 (0.76%) |
| Ex-dividend date | 11 Aug 2023 |
| 1y target est | N/A |
- Reuters
India's Divi's Labs Q1 profit slumps on drug pricing pressures
Indian pharmaceutical company Divi's Laboratories reported a 49.2% fall in quarterly profit, missing analysts' estimates, as the generic drug maker grappled with pricing pressures in key markets like the United States. The company reported a consolidated profit of 3.56 billion rupees ($42.9 million) for the first quarter ended June 30, compared to 7.02 billion rupees a year ago. Analysts, on an average, had expected a profit of 4.17 billion rupees, according to Refinitiv data.
© 2024 Yahoo. All rights reserved.